Showing results (141-150 of 297) with videos related to
Sort By:
Pageof 30
Breast Cancer Research and Treatment|May 19, 2018
Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jacek Gronwald, Henry T Lynch, et al.Breast Cancer Research and Treatment|January 25, 2024
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?Kerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.Future Oncology (London, England)|August 30, 2022
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutationsJordi Rodón, Pauline Funchain, Theodore W Laetsch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2010
Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patientsJeff Sperinde, Xueguang Jin, Jayee Banerjee, et al.Breast (Edinburgh, Scotland)|February 22, 2025
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trialsKerstin Wimmer, Dominik Hlauschek, Marija Balic, et al.JAMA Oncology|May 1, 2018
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation CarriersJoanne Kotsopoulos, Jacek Gronwald, Beth Y Karlan, et al.Gynecologic Oncology|May 26, 2018
Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Beth Karlan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8Martin Filipits, Margaretha Rudas, Verena Kainz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14Günther G Steger, Arik Galid, Michael Gnant, et al.Gynecologic Oncology|April 9, 2013
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort studyYakir Segev, Javaid Iqbal, Jan Lubinski, et al.Pageof 30